Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-19

Clinical Trial Update: Immune Mechanisms of Vitamin D to Reduce Chronic Pain After Burn [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether Vitamin D can modulate immune mechanisms to reduce chronic pain after burn injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Burn Injury, Chronic Pain | Phase 2 | Status: COMPLETED